Literature DB >> 3191940

A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.

V Savarino1, G S Mela, P Scalabrini, G Fera, P Zentilin, A Sumberaz, G Celle.   

Abstract

In order to assess whether dinnertime administration of a once daily dose of famotidine is more advantageous than a bedtime dose in suppressing evening and nocturnal gastric acidity, we gave nine patients with a past history of duodenal ulcer in double-blind, randomized fashion either (1) placebo at 6 p.m. and 10 p.m., (2) famotidine 40 mg at 6 p.m. (Fam 6) + placebo at 10 p.m. or (3) placebo at 6 p.m. + famotidine at 10 p.m. (Fam 10) on three separate occasions. Comparison of the 24-h median pH values showed that the two administrations of famotidine were superior to placebo, while Fam 6 was significantly more effective than Fam 10. The gain in acid suppression of Fam 6 with respect to Fam 10 was particularly evident from 6 p.m. to midnight. Although the antisecretory effectiveness of Fam 6 was lower than that of Fam 10 from 4 a.m. to 8 a.m., it remained clearly higher than that of placebo and ensured virtual anacidity (median pH = 6.7) even in this time segment. We conclude that a once daily dose of famotidine at 6 p.m. is better than bedtime administration at covering the long period of continuous unbuffered intragastric acidity which extends from after the evening meal to breakfast.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191940     DOI: 10.1007/bf00609254

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  A comparison of the nocturnal gastric secretion in patients with duodenal ulcer and in normal individuals.

Authors:  E LEVIN; J B KIRSNER
Journal:  Gastroenterology       Date:  1948-06       Impact factor: 22.682

2.  Famotidine and ranitidine control of 24 h intragastric acidity after single bedtime administration: a study using continuous pH monitoring.

Authors:  V Savarino; G S Mela; P Scalabrini; E Di Timoteo; M R Magnolia; G Percario; G Celle
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

3.  Twenty four hour intragastric acidity analysis for the future.

Authors:  R Walt
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

4.  24-hour intragastric pH: continuous monitoring or nasogastric aspiration?

Authors:  J R Reynolds; R P Walt; J D Hardcastle; A G Clark; H L Smart; M J Langman
Journal:  Digestion       Date:  1986       Impact factor: 3.216

5.  Reduction of gastric acidity with ranitidine or famotidine: early evening dosage is more effective than late evening dosage.

Authors:  P Bauerfeind; T Cilluffo; C Emde; C Fimmel; W Kohler; T Gasser; A L Blum
Journal:  Digestion       Date:  1987       Impact factor: 3.216

6.  Circadian rhythm of gastric acid secretion in men with active duodenal ulcer.

Authors:  J G Moore; F Halberg
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

7.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

8.  Continuous 24 hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients. A preliminary report.

Authors:  V Savarino; G S Mela; P Scalabrini; M R Magnolia; E Di Timoteo; G Percario; G Celle
Journal:  Gastroenterol Clin Biol       Date:  1986-12

9.  Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.

Authors:  J M Howard; A N Chremos; M J Collen; K E McArthur; J A Cherner; P N Maton; C A Ciarleglio; M J Cornelius; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

10.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

View more
  2 in total

Review 1.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

2.  Long-term in vivo imaging of Drosophila larvae.

Authors:  Parisa Kakanj; Sabine A Eming; Linda Partridge; Maria Leptin
Journal:  Nat Protoc       Date:  2020-02-10       Impact factor: 13.491

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.